Surgalign Holdings, Inc. provided revenue guidance for the year 2022. The company estimates it will report full year 2022 revenue of approximately $82.0 million.
Surgalign Holdings, Inc.
Equities
SRGA
US86882C2044
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
+9.13% | 34.16B | |
+24.97% | 8.13B | |
+30.81% | 4.44B | |
-28.73% | 2.7B | |
-17.78% | 1.37B | |
-28.50% | 1.27B | |
-32.48% | 1.18B | |
+12.20% | 1B | |
-37.86% | 870M |